Synergistic inhibition of human immunodeficiency virus type 1 (HIV-1) replication in vitro by 1-[(2-hydroxyethoxy)methyl]-6-phenylthiothymine (HEPT) and recombinant alpha interferon

Add time:08/27/2019    Source:sciencedirect.com

1-[(2-Hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT) has recently proved to be a potent and selective inhibitor of human immunodeficiency virus type 1 (HIV-1) in vitro. Combinations of HEPT and recombinant alpha interferon (IFN-α) synergistically inhibit the replication of HIV-1 in MT-4 cells at non-toxic concentrations. Synergistic inhibition of HIV-1 replication has also been observed in peripheral blood lymphocytes. These results indicate that the combination of HEPT with IFN-α should be further pursued in the treatment of retrovirus infections [i.e. acquired immune deficiency syndrome (AIDS)].

We also recommend Trading Suppliers and Manufacturers of 1-(1-(2-hydroxyethoxy)-3-azidopropyl)thymine (cas 117068-45-8). Pls Click Website Link as below: cas 117068-45-8 suppliers

Prev:ReviewChemical diversity and activity profiles of HIV-1 reverse transcriptase inhibitors from plants
Next:Dihydropyrimidinone-isatin hybrids as novel non-nucleoside HIV-1 reverse transcriptase inhibitors)